MPL and autoimmune thrombocytopenic purpura: Treatment modalities used for ITP include patients, not on medication n=8, steroids n=39, danazol n=3, splenectomy n=10, one patient with splenic artery embolization, intravenous immune globulin (IVIG) n=13, platelet transfusion n=3, a thrombopoietin receptor agonist eltrombopag n=9, romiplostim n=3, rituximab n=1, and 17 patients with no mention of previous treatment.